Your email has been successfully added to our mailing list.

×
-0.00621118012422369 -0.00122981366459628 0.00593788819875783 0.0135403726708074 0.00248447204968939 -0.0372546583850932 -0.0770186335403727 -0.0844844720496895
Stock impact report

Proteostasis stock rises 22% on FDA designation, smaller-than-expected Q4 loss [MarketWatch]

PROTEOSTASIS THERAPEUTICS (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
Company Research Source: MarketWatch
Proteostasis stock rises 22% on FDA designation, smaller-than-expected Q4 loss Proteostasis Therapeutics Inc. PTI, +24.10% shares rose 22% in premarket trade Thursday after the company reported a smaller-than-expected fourth-quarter loss and said its cystic fibrosis drug had been granted orphan drug designation by the Food and Drug Administration. Orphan drug designation allows for seven years of marketing exclusivity along with federal grants, tax credits and waived administrative filing fees; the drug, PTI-428, previously received a breakthrough therapy designation as well. Also late Wednesday, the company reported a fourth-quarter loss of $13.4 million, compared with the FactSet consensus of a loss of $16.3 million. Its cash, cash equivalents and short-term investments came to $74.5 million as of the end of 2017, which the company expects will fund its expenses into early 2019. Proteostasis shares have surged 31.4% over the last three months to $6.56, compared with a 2.8% rise i Show less Read more
Impact Snapshot
Event Time:
PTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PTI alerts
Opt-in for
PTI alerts

from News Quantified
Opt-in for
PTI alerts

from News Quantified